Current Research Studies

Noninvasive Biomarkers of Hepatic Fibrosis in Urea Cycle Disorders

UCDC Liver Study

Phase: N/A
Clinicaltrials.gov ID: NCT04612764

What is the goal of the study?

Primary Study Objective: To assess risk for increased fibrosis using serum biomarkers and/or patented vibration-controlled transient elastography technology (VCTE using Fibroscan®) in distal disorders (argininosuccinate synthetase deficiency or ASS1D, argininosuccinate lyase deficiency or ASLD, and arginase deficiency or ARG1D) as compared to ornithine transcarbamylase deficiency (OTCD)

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Christina Lam
Study Team Member: Hayden Vreugdenhil, [email protected]